ONTOLOGY REPORT - ANNOTATIONS
| Term: | all-trans-retinol |
|
| Accession: | CHEBI:17336
|
browse the term
|
| Definition: | A retinol in which all four exocyclic double bonds have E- (trans-) geometry. |
| Synonyms: | related_synonym: | (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol; Alphalin; C20H30O; CC(\\C=C\\C=C(C)\\C=C\\C1=C(C)CCCC1(C)C)=C/CO; Chocola A; InChI=1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3/b9-6+,12-11+,16-8+,17-13+; InChIKey=FPIPGXGPPPQFEQ-OVSJKPMPSA-N; Retinol; Vitamin A; Vitamin A1; all-trans-retinyl alcohol; all-trans-vitamin A alcohol |
| | alt_id: | CHEBI:12783; CHEBI:22349; CHEBI:8816 |
| | xref_casrn: | 11103-57-4; 68-26-8 |
| | xref: | Beilstein:403040 "Beilstein Registry Number"; ChEMBL:204574 "ChEMBL COMPOUND"; ChemIDplus:68-26-8 "CAS Registry Number"; DrugBank:DB00162 "DrugBank"; Gmelin:247497 "Gmelin Registry Number"; KEGG COMPOUND:11103-57-4 "CAS Registry Number"; KEGG COMPOUND:68-26-8 "CAS Registry Number"; KEGG COMPOUND:C00473 "KEGG COMPOUND"; KEGG DRUG:D00069 "KEGG DRUG"; LIPID MAPS:LMPR01090000 "LIPID MAPS instance"; LIPID MAPS:LMPR01090001 "LIPID MAPS instance" |
| | xref_mesh: | MESH:D014801 |
| | xref: | NIST Chemistry WebBook:68-26-8 "CAS Registry Number"; Wikipedia:Vitamin_A "Wikipedia" |
|
|
all-trans-retinol
|
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
EXP |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
decreases expression |
EXP |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Actg2 |
actin, gamma 2, smooth muscle, enteric |
|
decreases expression |
EXP |
4 |
117,732,482 |
117,747,006 |
RGD:6480464 |
CTD |
| G |
Actg2 |
actin, gamma 2, smooth muscle, enteric |
|
multiple interactions |
EXP |
4 |
117,732,482 |
117,747,006 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
increases expression |
EXP |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Ager |
advanced glycosylation end product-specific receptor |
|
multiple interactions |
EXP |
20 |
4,250,613 |
4,253,540 |
RGD:6480464 |
CTD |
| G |
Ager |
advanced glycosylation end product-specific receptor |
|
increases expression |
EXP |
20 |
4,250,613 |
4,253,540 |
RGD:6480464 |
CTD |
| G |
Ager |
advanced glycosylation end product-specific receptor |
|
multiple interactions |
EXP |
20 |
4,250,613 |
4,253,540 |
RGD:6480464 |
CTD |
| G |
Ager |
advanced glycosylation end product-specific receptor |
|
increases expression |
EXP |
20 |
4,250,613 |
4,253,540 |
RGD:6480464 |
CTD |
| G |
Ager |
advanced glycosylation end product-specific receptor |
|
increases expression |
EXP |
20 |
4,250,613 |
4,253,540 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Akr1b1 |
aldo-keto reductase family 1, member B1 (aldose reductase) |
|
decreases response to substance |
ISO |
4 |
61,645,438 |
61,659,530 |
RGD:6480464 |
CTD |
| G |
Akr1b10 |
aldo-keto reductase family 1, member B10 (aldose reductase) |
|
decreases response to substance |
ISO |
4 |
61,755,871 |
61,771,264 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
affects binding |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Amy2a3 |
amylase 2a3 |
|
multiple interactions |
ISO |
2 |
209,507,212 |
209,518,455 |
RGD:6480464 |
CTD |
| G |
Aox1 |
aldehyde oxidase 1 |
|
multiple interactions |
ISO |
9 |
56,693,698 |
56,774,115 |
RGD:6480464 |
CTD |
| G |
Apod |
apolipoprotein D |
|
affects binding |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
EXP |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
affects expression |
EXP |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
Ascl1 |
achaete-scute complex homolog 1 (Drosophila) |
|
increases expression |
EXP |
7 |
24,145,578 |
24,168,494 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
affects expression |
ISO |
15 |
22,283,171 |
22,286,757 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
increases expression |
ISO |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
affects activity |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
decreases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 molecule |
|
increases expression |
ISO |
18 |
29,374,593 |
29,376,190 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
increases expression |
ISO |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
affects expression |
ISO |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
multiple interactions |
ISO |
7 |
136,679,219 |
136,707,976 |
RGD:6480464 |
CTD |
| G |
Col4a2 |
collagen, type IV, alpha 2 |
|
increases expression |
ISO |
16 |
82,899,206 |
83,045,102 |
RGD:6480464 |
CTD |
| G |
Crabp2 |
cellular retinoic acid binding protein 2 |
|
multiple interactions |
ISO |
2 |
180,029,801 |
180,034,147 |
RGD:6480464 |
CTD |
| G |
Crabp2 |
cellular retinoic acid binding protein 2 |
|
increases expression |
ISO |
2 |
180,029,801 |
180,034,147 |
RGD:6480464 |
CTD |
| G |
Crabp2 |
cellular retinoic acid binding protein 2 |
|
increases expression |
ISO |
2 |
180,029,801 |
180,034,147 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
increases phosphorylation |
ISO |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
EXP |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
increases phosphorylation |
EXP |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
decreases expression |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
affects localization |
EXP |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases oxidation |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases oxidation |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
241,945,472 |
241,949,220 |
RGD:6480464 |
CTD |
| G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
1 |
241,945,472 |
241,949,220 |
RGD:6480464 |
CTD |
| G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
affects metabolic processing |
ISO |
1 |
241,945,472 |
241,949,220 |
RGD:6480464 |
CTD |
| G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
241,945,472 |
241,949,220 |
RGD:6480464 |
CTD |
| G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
1 |
241,945,472 |
241,949,220 |
RGD:6480464 |
CTD |
| G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
|
multiple interactions |
EXP |
4 |
118,734,786 |
118,751,606 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
multiple interactions |
EXP |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
affects activity |
ISO |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
|
multiple interactions |
ISO |
7 |
114,552,051 |
114,562,423 |
RGD:6480464 |
CTD |
| G |
Dhrs9 |
dehydrogenase/reductase (SDR family) member 9 |
|
increases metabolic processing |
ISO |
3 |
51,521,343 |
51,543,552 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases expression |
EXP |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Epo |
erythropoietin |
|
increases expression |
ISO |
12 |
19,551,768 |
19,555,208 |
RGD:6480464 |
CTD |
| G |
Epo |
erythropoietin |
|
multiple interactions |
EXP |
12 |
19,551,768 |
19,555,208 |
RGD:6480464 |
CTD |
| G |
Epo |
erythropoietin |
|
increases expression |
EXP |
12 |
19,551,768 |
19,555,208 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
decreases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
decreases secretion |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fnta |
farnesyltransferase, CAAX box, alpha |
|
multiple interactions |
EXP |
16 |
70,440,340 |
70,458,433 |
RGD:6480464 |
CTD |
| G |
Fntb |
farnesyltransferase, CAAX box, beta |
|
multiple interactions |
EXP |
6 |
99,427,967 |
99,511,373 |
RGD:6480464 |
CTD |
| G |
Fntb |
farnesyltransferase, CAAX box, beta |
|
increases expression |
EXP |
6 |
99,427,967 |
99,511,373 |
RGD:6480464 |
CTD |
| G |
Foxa1 |
forkhead box A1 |
|
increases expression |
ISO |
6 |
77,976,384 |
78,009,176 |
RGD:6480464 |
CTD |
| G |
Foxa2 |
forkhead box A2 |
|
multiple interactions |
EXP |
3 |
136,739,009 |
136,743,204 |
RGD:6480464 |
CTD |
| G |
Gabrb3 |
gamma-aminobutyric acid (GABA) A receptor, beta 3 |
|
increases expression |
ISO |
1 |
109,047,399 |
109,277,756 |
RGD:6480464 |
CTD |
| G |
Gata6 |
GATA binding protein 6 |
|
increases expression |
ISO |
18 |
2,504,264 |
2,534,648 |
RGD:6480464 |
CTD |
| G |
Gcg |
glucagon |
|
multiple interactions |
ISO |
3 |
44,433,180 |
44,438,004 |
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
multiple interactions |
EXP |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
multiple interactions |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases expression |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gnai1 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
|
increases expression |
EXP |
4 |
12,465,089 |
12,495,028 |
RGD:6480464 |
CTD |
| G |
Gnai2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
|
increases expression |
EXP |
8 |
112,861,952 |
112,882,647 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
increases activity |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Grhl3 |
grainyhead-like 3 (Drosophila) |
|
increases response to substance |
ISO |
5 |
154,312,655 |
154,344,656 |
RGD:6480464 |
CTD |
| G |
Hbegf |
heparin-binding EGF-like growth factor |
|
increases expression |
ISO |
18 |
29,143,567 |
29,153,944 |
RGD:6480464 |
CTD |
| G |
Hist3h3 |
histone cluster 3, H3 |
|
increases acetylation |
ISO |
10 |
45,252,993 |
45,253,403 |
RGD:6480464 |
CTD |
| G |
Hist3h3 |
histone cluster 3, H3 |
|
multiple interactions |
ISO |
10 |
45,252,993 |
45,253,403 |
RGD:6480464 |
CTD |
| G |
Hoxa3 |
homeobox A3 |
|
affects expression |
ISO |
4 |
80,468,987 |
80,513,111 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
decreases expression |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
affects expression |
EXP |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
increases expression |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
decreases expression |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Inhba |
inhibin beta-A |
|
multiple interactions |
ISO |
17 |
57,244,466 |
57,257,531 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
ISO |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
multiple interactions |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Itga3 |
integrin, alpha 3 |
|
increases expression |
ISO |
10 |
83,728,710 |
83,759,576 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin, beta 1 |
|
affects localization |
ISO |
19 |
58,600,095 |
58,647,531 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin, beta 1 |
|
increases expression |
ISO |
19 |
58,600,095 |
58,647,531 |
RGD:6480464 |
CTD |
| G |
Ivl |
involucrin |
|
increases expression |
ISO |
2 |
185,556,271 |
185,558,310 |
RGD:6480464 |
CTD |
| G |
Jak2 |
Janus kinase 2 |
|
affects localization |
EXP |
1 |
232,915,995 |
232,974,763 |
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt19 |
keratin 19 |
|
increases expression |
ISO |
10 |
89,080,953 |
89,085,670 |
RGD:6480464 |
CTD |
| G |
Krt7 |
keratin 7 |
|
increases expression |
ISO |
7 |
140,160,829 |
140,226,474 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
increases expression |
ISO |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
EXP |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lrat |
lecithin-retinol acyltransferase (phosphatidylcholine-retinol-O-acyltransferase) |
|
multiple interactions |
ISO |
2 |
174,636,382 |
174,645,444 |
RGD:6480464 |
CTD |
| G |
Lrat |
lecithin-retinol acyltransferase (phosphatidylcholine-retinol-O-acyltransferase) |
|
multiple interactions |
ISO |
2 |
174,636,382 |
174,645,444 |
RGD:6480464 |
CTD |
| G |
Lrat |
lecithin-retinol acyltransferase (phosphatidylcholine-retinol-O-acyltransferase) |
|
increases expression |
ISO |
2 |
174,636,382 |
174,645,444 |
RGD:6480464 |
CTD |
| G |
Lrat |
lecithin-retinol acyltransferase (phosphatidylcholine-retinol-O-acyltransferase) |
|
affects expression |
EXP |
2 |
174,636,382 |
174,645,444 |
RGD:6480464 |
CTD |
| G |
Lrp2 |
low density lipoprotein receptor-related protein 2 |
|
multiple interactions |
ISO |
3 |
51,563,764 |
51,724,478 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
multiple interactions |
EXP |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
increases phosphorylation |
EXP |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
|
multiple interactions |
EXP |
7 |
10,074,654 |
10,094,003 |
RGD:6480464 |
CTD |
| G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
|
increases phosphorylation |
EXP |
7 |
10,074,654 |
10,094,003 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
multiple interactions |
ISO |
1 |
233,978,931 |
233,983,824 |
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Meis1 |
Meis homeobox 1 |
|
increases expression |
ISO |
14 |
99,693,567 |
99,832,273 |
RGD:6480464 |
CTD |
| G |
Meis1 |
Meis homeobox 1 |
|
multiple interactions |
ISO |
14 |
99,693,567 |
99,832,273 |
RGD:6480464 |
CTD |
| G |
Meis2 |
Meis homeobox 2 |
|
increases expression |
ISO |
3 |
101,915,966 |
102,117,215 |
RGD:6480464 |
CTD |
| G |
Meis2 |
Meis homeobox 2 |
|
multiple interactions |
ISO |
3 |
101,915,966 |
102,117,215 |
RGD:6480464 |
CTD |
| G |
Meox1 |
mesenchyme homeobox 1 |
|
increases expression |
ISO |
10 |
90,921,589 |
90,942,298 |
RGD:6480464 |
CTD |
| G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Ncoa1 |
nuclear receptor coactivator 1 |
|
multiple interactions |
ISO |
6 |
27,224,396 |
27,473,926 |
RGD:6480464 |
CTD |
| G |
Nkx2-1 |
NK2 homeobox 1 |
|
multiple interactions |
ISO |
6 |
76,916,943 |
76,920,133 |
RGD:6480464 |
CTD |
| G |
Nkx2-1 |
NK2 homeobox 1 |
|
multiple interactions |
EXP |
6 |
76,916,943 |
76,920,133 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases expression |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Npy1r |
neuropeptide Y receptor Y1 |
|
increases response to substance |
ISO |
16 |
24,747,183 |
24,756,507 |
RGD:6480464 |
CTD |
| G |
Nrgn |
neurogranin |
|
affects expression |
EXP |
8 |
38,790,596 |
38,799,077 |
RGD:6480464 |
CTD |
| G |
Olr1 |
oxidized low density lipoprotein (lectin-like) receptor 1 |
|
increases expression |
ISO |
4 |
166,747,228 |
166,769,340 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
affects expression |
EXP |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
Pax3 |
paired box 3 |
|
multiple interactions |
EXP |
9 |
77,477,813 |
77,576,632 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
affects expression |
ISO |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
multiple interactions |
ISO |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
multiple interactions |
ISO |
3 |
164,012,410 |
164,018,359 |
RGD:6480464 |
CTD |
| G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
increases expression |
EXP |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
multiple interactions |
ISO |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppy |
pancreatic polypeptide |
|
multiple interactions |
ISO |
10 |
91,167,958 |
91,169,253 |
RGD:6480464 |
CTD |
| G |
Ptf1a |
pancreas specific transcription factor, 1a |
|
multiple interactions |
ISO |
17 |
93,494,689 |
93,496,543 |
RGD:6480464 |
CTD |
| G |
Ptgds |
prostaglandin D2 synthase (brain) |
|
affects binding |
ISO |
3 |
3,632,683 |
3,635,617 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptpn6 |
protein tyrosine phosphatase, non-receptor type 6 |
|
multiple interactions |
EXP |
4 |
160,843,699 |
160,868,856 |
RGD:6480464 |
CTD |
| G |
Rara |
retinoic acid receptor, alpha |
|
multiple interactions |
ISO |
10 |
87,740,479 |
87,753,265 |
RGD:6480464 |
CTD |
| G |
Rara |
retinoic acid receptor, alpha |
|
increases expression |
ISO |
10 |
87,740,479 |
87,753,265 |
RGD:6480464 |
CTD |
| G |
Rara |
retinoic acid receptor, alpha |
|
multiple interactions |
ISO |
10 |
87,740,479 |
87,753,265 |
RGD:6480464 |
CTD |
| G |
Rara |
retinoic acid receptor, alpha |
|
increases expression |
EXP |
10 |
87,740,479 |
87,753,265 |
RGD:6480464 |
CTD |
| G |
Rara |
retinoic acid receptor, alpha |
|
increases expression |
ISO |
10 |
87,740,479 |
87,753,265 |
RGD:6480464 |
CTD |
| G |
Rarb |
retinoic acid receptor, beta |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rarb |
retinoic acid receptor, beta |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rarb |
retinoic acid receptor, beta |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rarb |
retinoic acid receptor, beta |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rarb |
retinoic acid receptor, beta |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rarb |
retinoic acid receptor, beta |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rarb |
retinoic acid receptor, beta |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rarb |
retinoic acid receptor, beta |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rarg |
retinoic acid receptor, gamma |
|
multiple interactions |
ISO |
7 |
140,991,447 |
141,014,108 |
RGD:6480464 |
CTD |
| G |
Rarres1 |
retinoic acid receptor responder (tazarotene induced) 1 |
|
increases expression |
ISO |
2 |
157,332,213 |
157,367,137 |
RGD:6480464 |
CTD |
| G |
Rbp1 |
retinol binding protein 1, cellular |
|
increases uptake |
ISO |
8 |
103,605,870 |
103,627,390 |
RGD:6480464 |
CTD |
| G |
Rbp1 |
retinol binding protein 1, cellular |
|
increases expression |
ISO |
8 |
103,605,870 |
103,627,390 |
RGD:6480464 |
CTD |
| G |
Rbp1 |
retinol binding protein 1, cellular |
|
affects expression |
EXP |
8 |
103,605,870 |
103,627,390 |
RGD:6480464 |
CTD |
| G |
Rbp1 |
retinol binding protein 1, cellular |
|
multiple interactions |
ISO |
8 |
103,605,870 |
103,627,390 |
RGD:6480464 |
CTD |
| G |
Rbp1 |
retinol binding protein 1, cellular |
|
increases abundance |
ISO |
8 |
103,605,870 |
103,627,390 |
RGD:6480464 |
CTD |
| G |
Rbp4 |
retinol binding protein 4, plasma |
|
affects binding |
ISO |
1 |
242,443,795 |
242,450,997 |
RGD:6480464 |
CTD |
| G |
Rbp4 |
retinol binding protein 4, plasma |
|
affects binding |
ISO |
1 |
242,443,795 |
242,450,997 |
RGD:6480464 |
CTD |
| G |
Rbp4 |
retinol binding protein 4, plasma |
|
affects binding |
ISO |
1 |
242,443,795 |
242,450,997 |
RGD:6480464 |
CTD |
| G |
Rbp4 |
retinol binding protein 4, plasma |
|
affects binding |
ISO |
1 |
242,443,795 |
242,450,997 |
RGD:6480464 |
CTD |
| G |
Rbp4 |
retinol binding protein 4, plasma |
|
decreases secretion |
ISO |
1 |
242,443,795 |
242,450,997 |
RGD:6480464 |
CTD |
| G |
Rbp4 |
retinol binding protein 4, plasma |
|
increases secretion |
ISO |
1 |
242,443,795 |
242,450,997 |
RGD:6480464 |
CTD |
| G |
Rbp4 |
retinol binding protein 4, plasma |
|
multiple interactions |
ISO |
1 |
242,443,795 |
242,450,997 |
RGD:6480464 |
CTD |
| G |
Rbp4 |
retinol binding protein 4, plasma |
|
multiple interactions |
ISO |
1 |
242,443,795 |
242,450,997 |
RGD:6480464 |
CTD |
| G |
Rdh10 |
retinol dehydrogenase 10 (all-trans) |
|
increases oxidation |
ISO |
5 |
2,286,373 |
2,314,154 |
RGD:6480464 |
CTD |
| G |
Rdh11 |
retinol dehydrogenase 11 (all-trans/9-cis/11-cis) |
|
increases oxidation |
ISO |
6 |
101,946,431 |
101,962,606 |
RGD:6480464 |
CTD |
| G |
Rdh12 |
retinol dehydrogenase 12 (all-trans/9-cis/11-cis) |
|
increases chemical synthesis |
ISO |
6 |
101,982,815 |
101,995,737 |
RGD:6480464 |
CTD |
| G |
Rdh5 |
retinol dehydrogenase 5 (11-cis/9-cis) |
|
increases oxidation |
ISO |
7 |
2,212,121 |
2,217,394 |
RGD:6480464 |
CTD |
| G |
Retn |
resistin |
|
decreases expression |
ISO |
12 |
2,499,630 |
2,501,370 |
RGD:6480464 |
CTD |
| G |
Rhoa |
ras homolog family member A |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rhoa |
ras homolog family member A |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rhob |
ras homolog family member B |
|
multiple interactions |
EXP |
6 |
32,052,333 |
32,054,507 |
RGD:6480464 |
CTD |
| G |
Rhob |
ras homolog family member B |
|
increases expression |
EXP |
6 |
32,052,333 |
32,054,507 |
RGD:6480464 |
CTD |
| G |
Rpe65 |
retinal pigment epithelium 65 |
|
increases chemical synthesis |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rpe65 |
retinal pigment epithelium 65 |
|
increases metabolic processing |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Runx2 |
runt-related transcription factor 2 |
|
multiple interactions |
ISO |
9 |
11,869,234 |
12,025,219 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
multiple interactions |
ISO |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
increases expression |
ISO |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
increases expression |
EXP |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
Rxrb |
retinoid X receptor beta |
|
affects expression |
EXP |
20 |
4,954,336 |
4,960,880 |
RGD:6480464 |
CTD |
| G |
Rxrg |
retinoid X receptor gamma |
|
affects expression |
EXP |
13 |
83,256,823 |
83,298,724 |
RGD:6480464 |
CTD |
| G |
Rxrg |
retinoid X receptor gamma |
|
increases expression |
ISO |
13 |
83,256,823 |
83,298,724 |
RGD:6480464 |
CTD |
| G |
Sdr16c5 |
short chain dehydrogenase/reductase family 16C, member 5 |
|
increases oxidation |
ISO |
5 |
17,339,715 |
17,361,781 |
RGD:6480464 |
CTD |
| G |
Sftpb |
surfactant protein B |
|
multiple interactions |
EXP |
4 |
105,609,410 |
105,618,452 |
RGD:6480464 |
CTD |
| G |
Sftpb |
surfactant protein B |
|
multiple interactions |
ISO |
4 |
105,609,410 |
105,618,452 |
RGD:6480464 |
CTD |
| G |
Sftpb |
surfactant protein B |
|
multiple interactions |
EXP |
4 |
105,609,410 |
105,618,452 |
RGD:6480464 |
CTD |
| G |
Sftpc |
surfactant protein C |
|
multiple interactions |
EXP |
15 |
50,923,105 |
50,926,047 |
RGD:6480464 |
CTD |
| G |
Sftpc |
surfactant protein C |
|
decreases expression |
EXP |
15 |
50,923,105 |
50,926,047 |
RGD:6480464 |
CTD |
| G |
Shh |
sonic hedgehog |
|
multiple interactions |
ISO |
4 |
2,200,504 |
2,209,657 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
multiple interactions |
ISO |
3 |
87,870,558 |
87,992,401 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
increases expression |
ISO |
3 |
87,870,558 |
87,992,401 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
increases expression |
ISO |
3 |
87,870,558 |
87,992,401 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
decreases expression |
EXP |
13 |
107,980,864 |
107,986,519 |
RGD:6480464 |
CTD |
| G |
Slc30a2 |
solute carrier family 30 (zinc transporter), member 2 |
|
multiple interactions |
EXP |
5 |
153,086,346 |
153,098,569 |
RGD:6480464 |
CTD |
| G |
Slc30a4 |
solute carrier family 30 (zinc transporter), member 4 |
|
increases expression |
EXP |
3 |
109,643,714 |
109,665,750 |
RGD:6480464 |
CTD |
| G |
Sox17 |
SRY (sex determining region Y)-box 17 |
|
multiple interactions |
ISO |
5 |
15,241,405 |
15,246,904 |
RGD:6480464 |
CTD |
| G |
Sox9 |
SRY (sex determining region Y)-box 9 |
|
multiple interactions |
ISO |
10 |
102,392,187 |
102,394,256 |
RGD:6480464 |
CTD |
| G |
Sox9 |
SRY (sex determining region Y)-box 9 |
|
multiple interactions |
ISO |
10 |
102,392,187 |
102,394,256 |
RGD:6480464 |
CTD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
multiple interactions |
EXP |
3 |
148,157,256 |
148,170,524 |
RGD:6480464 |
CTD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
increases phosphorylation |
EXP |
3 |
148,157,256 |
148,170,524 |
RGD:6480464 |
CTD |
| G |
Sst |
somatostatin |
|
multiple interactions |
ISO |
11 |
79,125,031 |
79,126,216 |
RGD:6480464 |
CTD |
| G |
Sst |
somatostatin |
|
affects expression |
EXP |
11 |
79,125,031 |
79,126,216 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
affects expression |
EXP |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stat5a |
signal transducer and activator of transcription 5A |
|
multiple interactions |
EXP |
10 |
89,795,404 |
89,819,732 |
RGD:6480464 |
CTD |
| G |
Stra6 |
stimulated by retinoic acid 6 |
|
multiple interactions |
ISO |
8 |
61,920,772 |
61,939,791 |
RGD:6480464 |
CTD |
| G |
Stra6 |
stimulated by retinoic acid 6 |
|
increases transport |
ISO |
8 |
61,920,772 |
61,939,791 |
RGD:6480464 |
CTD |
| G |
Stra8 |
stimulated by retinoic acid 8 |
|
increases expression |
ISO |
4 |
62,321,565 |
62,336,954 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
decreases expression |
ISO |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tgfa |
transforming growth factor alpha |
|
increases expression |
EXP |
4 |
120,355,649 |
120,437,772 |
RGD:6480464 |
CTD |
| G |
Tgfb3 |
transforming growth factor, beta 3 |
|
increases expression |
ISO |
6 |
110,173,443 |
110,195,215 |
RGD:6480464 |
CTD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
increases expression |
ISO |
8 |
120,593,595 |
120,680,453 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
increases expression |
ISO |
3 |
148,832,866 |
148,862,385 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
affects expression |
EXP |
3 |
148,832,866 |
148,862,385 |
RGD:6480464 |
CTD |
| G |
Tlr2 |
toll-like receptor 2 |
|
increases expression |
ISO |
2 |
175,607,990 |
175,613,992 |
RGD:6480464 |
CTD |
| G |
Tlr4 |
toll-like receptor 4 |
|
increases expression |
ISO |
5 |
83,564,100 |
83,577,735 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
affects secretion |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tob1 |
transducer of ErbB-2.1 |
|
multiple interactions |
ISO |
10 |
82,852,405 |
82,854,443 |
RGD:6480464 |
CTD |
| G |
Tob1 |
transducer of ErbB-2.1 |
|
increases expression |
ISO |
10 |
82,852,405 |
82,854,443 |
RGD:6480464 |
CTD |
| G |
Tpi1 |
triosephosphate isomerase 1 |
|
increases expression |
EXP |
4 |
160,933,341 |
160,936,871 |
RGD:6480464 |
CTD |
| G |
Ucp1 |
uncoupling protein 1 (mitochondrial, proton carrier) |
|
multiple interactions |
EXP |
19 |
26,527,548 |
26,535,621 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
multiple interactions |
EXP |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a6 |
UDP glucuronosyltransferase 1 family, polypeptide A6 |
|
multiple interactions |
EXP |
9 |
87,037,154 |
87,098,362 |
RGD:6480464 |
CTD |
all-trans-retinyl palmitate
|
| G |
Cat |
catalase |
|
increases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ep300 |
E1A binding protein p300 |
|
multiple interactions |
EXP |
7 |
119,938,507 |
120,008,886 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
multiple interactions |
ISO |
3 |
2,607,800 |
2,613,216 |
RGD:6480464 |
CTD |
| G |
Lipe |
lipase, hormone sensitive |
|
increases hydrolysis |
ISO |
1 |
80,663,791 |
80,682,480 |
RGD:6480464 |
CTD |
| G |
Lipe |
lipase, hormone sensitive |
|
multiple interactions |
ISO |
1 |
80,663,791 |
80,682,480 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Plin3 |
perilipin 3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rara |
retinoic acid receptor, alpha |
|
multiple interactions |
EXP |
10 |
87,740,479 |
87,753,265 |
RGD:6480464 |
CTD |
| G |
Scarb1 |
scavenger receptor class B, member 1 |
|
increases expression |
EXP |
12 |
32,390,183 |
32,457,661 |
RGD:6480464 |
CTD |
retinyl acetate
|
| G |
Acvr2b |
activin A receptor, type IIB |
|
increases expression |
ISO |
8 |
124,364,330 |
124,395,748 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
affects binding |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Apoe |
apolipoprotein E |
|
increases expression |
ISO |
1 |
79,003,634 |
79,006,387 |
RGD:6480464 |
CTD |
| G |
Bcar1 |
breast cancer anti-estrogen resistance 1 |
|
increases expression |
ISO |
19 |
41,646,190 |
41,669,234 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
increases expression |
ISO |
15 |
22,283,171 |
22,286,757 |
RGD:6480464 |
CTD |
| G |
Bmp7 |
bone morphogenetic protein 7 |
|
increases expression |
ISO |
3 |
163,723,429 |
163,799,567 |
RGD:6480464 |
CTD |
| G |
Calm1 |
calmodulin 1 |
|
increases expression |
ISO |
6 |
124,477,601 |
124,485,669 |
RGD:6480464 |
CTD |
| G |
Cbl |
Cbl proto-oncogene, E3 ubiquitin protein ligase |
|
increases expression |
ISO |
8 |
47,135,357 |
47,211,889 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
increases expression |
ISO |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
increases expression |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Cdx2 |
caudal type homeo box 2 |
|
increases expression |
ISO |
12 |
8,296,103 |
8,303,643 |
RGD:6480464 |
CTD |
| G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
|
increases expression |
ISO |
17 |
19,423,502 |
19,429,451 |
RGD:6480464 |
CTD |
| G |
Crk |
v-crk sarcoma virus CT10 oncogene homolog (avian) |
|
increases expression |
ISO |
10 |
63,017,662 |
63,040,420 |
RGD:6480464 |
CTD |
| G |
Csnk2a1 |
casein kinase 2, alpha 1 polypeptide |
|
increases expression |
ISO |
3 |
142,564,754 |
142,609,311 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
increases expression |
ISO |
15 |
42,402,829 |
42,423,701 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
increases expression |
ISO |
1 |
202,619,669 |
202,631,545 |
RGD:6480464 |
CTD |
| G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
241,945,472 |
241,949,220 |
RGD:6480464 |
CTD |
| G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
1 |
241,945,472 |
241,949,220 |
RGD:6480464 |
CTD |
| G |
Dcn |
decorin |
|
increases expression |
ISO |
7 |
35,004,234 |
35,045,191 |
RGD:6480464 |
CTD |
| G |
Dlx3 |
distal-less homeobox 3 |
|
increases expression |
ISO |
10 |
83,802,169 |
83,807,565 |
RGD:6480464 |
CTD |
| G |
Dnajc3 |
DnaJ (Hsp40) homolog, subfamily C, member 3 |
|
increases expression |
ISO |
15 |
103,881,634 |
103,921,295 |
RGD:6480464 |
CTD |
| G |
E2f3 |
E2F transcription factor 3 |
|
increases expression |
ISO |
17 |
41,079,346 |
41,145,568 |
RGD:6480464 |
CTD |
| G |
Ei24 |
etoposide induced 2.4 |
|
increases expression |
ISO |
8 |
38,028,043 |
38,044,316 |
RGD:6480464 |
CTD |
| G |
Eng |
endoglin |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ets2 |
v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) |
|
increases expression |
ISO |
11 |
36,014,047 |
36,030,833 |
RGD:6480464 |
CTD |
| G |
Eya2 |
eyes absent homolog 2 (Drosophila) |
|
increases expression |
ISO |
3 |
156,731,490 |
156,848,691 |
RGD:6480464 |
CTD |
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
increases expression |
ISO |
14 |
82,683,191 |
82,697,229 |
RGD:6480464 |
CTD |
| G |
Foxg1 |
forkhead box G1 |
|
increases expression |
ISO |
6 |
69,217,672 |
69,220,482 |
RGD:6480464 |
CTD |
| G |
Frzb |
frizzled-related protein |
|
increases expression |
ISO |
3 |
63,350,504 |
63,383,436 |
RGD:6480464 |
CTD |
| G |
Fxn |
frataxin |
|
increases expression |
ISO |
1 |
227,647,092 |
227,671,081 |
RGD:6480464 |
CTD |
| G |
Fzd3 |
frizzled family receptor 3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fzd6 |
frizzled family receptor 6 |
|
increases expression |
ISO |
7 |
74,562,307 |
74,594,014 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
ISO |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
increases expression |
ISO |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Hes1 |
hairy and enhancer of split 1 (Drosophila) |
|
increases expression |
ISO |
11 |
72,603,482 |
72,605,673 |
RGD:6480464 |
CTD |
| G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
increases expression |
ISO |
X |
139,929,647 |
139,961,616 |
RGD:6480464 |
CTD |
| G |
Hspa4l |
heat shock protein 4-like |
|
increases expression |
ISO |
2 |
127,697,504 |
127,751,085 |
RGD:6480464 |
CTD |
| G |
Hsph1 |
heat shock 105/110 protein 1 |
|
increases expression |
ISO |
12 |
5,794,645 |
5,811,453 |
RGD:6480464 |
CTD |
| G |
Id3 |
inhibitor of DNA binding 3 |
|
increases expression |
ISO |
5 |
154,934,138 |
154,935,707 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
increases expression |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il5 |
interleukin 5 |
|
affects response to substance |
ISO |
10 |
39,177,786 |
39,180,657 |
RGD:6480464 |
CTD |
| G |
Il5 |
interleukin 5 |
|
increases expression |
ISO |
10 |
39,177,786 |
39,180,657 |
RGD:6480464 |
CTD |
| G |
Il5ra |
interleukin 5 receptor, alpha |
|
affects response to substance |
ISO |
4 |
142,067,108 |
142,098,051 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Jund |
jun D proto-oncogene |
|
increases expression |
ISO |
16 |
19,239,694 |
19,241,529 |
RGD:6480464 |
CTD |
| G |
Kif1b |
kinesin family member 1B |
|
increases expression |
ISO |
5 |
166,250,225 |
166,381,782 |
RGD:6480464 |
CTD |
| G |
Kl |
Klotho |
|
increases expression |
ISO |
12 |
3,732,712 |
3,772,371 |
RGD:6480464 |
CTD |
| G |
Lama5 |
laminin, alpha 5 |
|
increases expression |
ISO |
3 |
169,233,897 |
169,282,410 |
RGD:6480464 |
CTD |
| G |
Laptm4a |
lysosomal protein transmembrane 4 alpha |
|
increases expression |
ISO |
6 |
32,410,289 |
32,427,917 |
RGD:6480464 |
CTD |
| G |
Lifr |
leukemia inhibitory factor receptor alpha |
|
increases expression |
ISO |
2 |
56,426,058 |
56,477,198 |
RGD:6480464 |
CTD |
| G |
Ltbr |
lymphotoxin beta receptor (TNFR superfamily, member 3) |
|
increases expression |
ISO |
4 |
161,431,864 |
161,438,265 |
RGD:6480464 |
CTD |
| G |
Map3k3 |
mitogen activated protein kinase kinase kinase 3 |
|
increases expression |
ISO |
10 |
95,482,303 |
95,551,065 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
increases expression |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapkapk2 |
mitogen-activated protein kinase-activated protein kinase 2 |
|
increases expression |
ISO |
13 |
43,994,943 |
44,041,504 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases expression |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Msx1 |
msh homeobox 1 |
|
increases expression |
ISO |
14 |
78,257,345 |
78,261,144 |
RGD:6480464 |
CTD |
| G |
Msx2 |
msh homeobox 2 |
|
increases expression |
ISO |
17 |
17,243,262 |
17,248,927 |
RGD:6480464 |
CTD |
| G |
Mycn |
v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) |
|
increases expression |
ISO |
6 |
36,508,262 |
36,514,071 |
RGD:6480464 |
CTD |
| G |
Myo1b |
myosin Ib |
|
increases expression |
ISO |
9 |
46,756,678 |
46,917,169 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases expression |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nid1 |
nidogen 1 |
|
increases expression |
ISO |
17 |
66,857,529 |
66,930,273 |
RGD:6480464 |
CTD |
| G |
Notch1 |
notch 1 |
|
increases expression |
ISO |
3 |
4,631,797 |
4,677,640 |
RGD:6480464 |
CTD |
| G |
Notch2 |
notch 2 |
|
increases expression |
ISO |
2 |
192,839,350 |
192,986,589 |
RGD:6480464 |
CTD |
| G |
Pea15 |
phosphoprotein enriched in astrocytes 15 |
|
increases expression |
ISO |
13 |
88,187,674 |
88,197,296 |
RGD:6480464 |
CTD |
| G |
Phgdh |
phosphoglycerate dehydrogenase |
|
increases expression |
ISO |
2 |
193,147,943 |
193,177,137 |
RGD:6480464 |
CTD |
| G |
Pik3r1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
increases expression |
ISO |
2 |
32,602,673 |
32,675,350 |
RGD:6480464 |
CTD |
| G |
Psen2 |
presenilin 2 |
|
increases expression |
ISO |
13 |
95,934,674 |
95,951,836 |
RGD:6480464 |
CTD |
| G |
Ptpn13 |
protein tyrosine phosphatase, non-receptor type 13 |
|
increases expression |
ISO |
14 |
7,298,209 |
7,433,464 |
RGD:6480464 |
CTD |
| G |
Rad50 |
RAD50 homolog (S. cerevisiae) |
|
increases expression |
ISO |
10 |
39,112,733 |
39,164,694 |
RGD:6480464 |
CTD |
| G |
Rangap1 |
RAN GTPase activating protein 1 |
|
increases expression |
ISO |
7 |
120,056,065 |
120,080,018 |
RGD:6480464 |
CTD |
| G |
Ror1 |
receptor tyrosine kinase-like orphan receptor 1 |
|
increases expression |
ISO |
5 |
120,746,419 |
121,098,205 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
increases expression |
ISO |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
Satb1 |
SATB homeobox 1 |
|
increases expression |
ISO |
9 |
3,307,651 |
3,391,348 |
RGD:6480464 |
CTD |
| G |
Sdc1 |
syndecan 1 |
|
increases expression |
ISO |
6 |
32,253,352 |
32,275,812 |
RGD:6480464 |
CTD |
| G |
Sim2 |
single-minded homolog 2 (Drosophila) |
|
increases expression |
ISO |
11 |
34,335,645 |
34,376,925 |
RGD:6480464 |
CTD |
| G |
Smn1 |
survival of motor neuron 1, telomeric |
|
increases expression |
ISO |
2 |
31,147,743 |
31,159,938 |
RGD:6480464 |
CTD |
| G |
Snai1 |
snail homolog 1 (Drosophila) |
|
increases expression |
ISO |
3 |
158,676,980 |
158,681,471 |
RGD:6480464 |
CTD |
| G |
Snai2 |
snail homolog 2 (Drosophila) |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Sqstm1 |
sequestosome 1 |
|
increases expression |
ISO |
10 |
35,751,300 |
35,762,630 |
RGD:6480464 |
CTD |
| G |
Tbx2 |
T-box 2 |
|
increases expression |
ISO |
10 |
74,085,203 |
74,092,988 |
RGD:6480464 |
CTD |
| G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
increases expression |
ISO |
7 |
19,677,144 |
19,727,072 |
RGD:6480464 |
CTD |
| G |
Tyro3 |
TYRO3 protein tyrosine kinase |
|
increases expression |
ISO |
3 |
106,309,671 |
106,328,607 |
RGD:6480464 |
CTD |
| G |
Wnt11 |
wingless-type MMTV integration site family, member 11 |
|
increases expression |
ISO |
1 |
156,125,969 |
156,142,065 |
RGD:6480464 |
CTD |
| G |
Wnt7b |
wingless-type MMTV integration site family, member 7B |
|
increases expression |
ISO |
7 |
123,533,713 |
123,554,333 |
RGD:6480464 |
CTD |
| G |
Ywhaz |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide |
|
increases expression |
ISO |
7 |
72,283,825 |
72,306,126 |
RGD:6480464 |
CTD |
Term paths to the root
|